Elsevier, Maverix Ink Software Integration Agreement | GenomeWeb

NEW YORK (GenomeWeb) – Maverix Biomics and Elsevier have signed an agreement that lets the companies integrate the Maverix Analytic platform with Elsevier's Pathway Studio software to improve the analysis and interpretation of next-generation sequencing data.

The companies made the announcement at the 23rd International Molecular Medicine Tri-Conference being held this week in San Francisco, Calif.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.